Eintrag weiter verarbeiten
Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience
Gespeichert in:
| Zeitschriftentitel: | Alimentary Pharmacology & Therapeutics |
|---|---|
| Personen und Körperschaften: | , , , , , , , |
| In: | Alimentary Pharmacology & Therapeutics, 31, 2010, 2, S. 253-260 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
DI BIASE, A. R. COLECCHIA, A. SCAIOLI, E. BERRI, R. VIOLA, L. VESTITO, A. BALLI, F. FESTI, D. DI BIASE, A. R. COLECCHIA, A. SCAIOLI, E. BERRI, R. VIOLA, L. VESTITO, A. BALLI, F. FESTI, D. |
|---|---|
| author |
DI BIASE, A. R. COLECCHIA, A. SCAIOLI, E. BERRI, R. VIOLA, L. VESTITO, A. BALLI, F. FESTI, D. |
| spellingShingle |
DI BIASE, A. R. COLECCHIA, A. SCAIOLI, E. BERRI, R. VIOLA, L. VESTITO, A. BALLI, F. FESTI, D. Alimentary Pharmacology & Therapeutics Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience Pharmacology (medical) Gastroenterology Hepatology |
| author_sort |
di biase, a. r. |
| spelling |
DI BIASE, A. R. COLECCHIA, A. SCAIOLI, E. BERRI, R. VIOLA, L. VESTITO, A. BALLI, F. FESTI, D. 0269-2813 1365-2036 Wiley Pharmacology (medical) Gastroenterology Hepatology http://dx.doi.org/10.1111/j.1365-2036.2009.04186.x <jats:title>Summary</jats:title><jats:p><jats:bold>Backgroud </jats:bold> Coeliac disease (CD) can be associated with liver disease. Gluten‐free diet (GFD) normalizes cryptogenic forms, but most likely not autoimmune hepatitis (AIH). For this condition, immunosuppressants represent the treatment. However, when these are stopped, AIH generally relapses.</jats:p><jats:p><jats:bold>Aim </jats:bold> To determine in CD children liver test abnormality frequency, the effect of GFD alone, or plus prolonged immunosuppressants on AIH course.</jats:p><jats:p><jats:bold>Methods </jats:bold> Coeliac disease patients with abnormal transaminases were selected; if transaminases <5 × UNL (upper normal limits), GFD alone was administered; if >5 × UNL, liver examinations and biopsy were performed. In AIH, immunosuppressants were administered (5 years). Treatment was stopped only if patients remained in remission during the entire maintenance period and normalized liver histology.</jats:p><jats:p><jats:bold>Results </jats:bold> A total of 140 out of 350 CD children had hypertransaminaemia: 133 cryptogenic disease, 7 AIH. GFD normalized only cryptogenic hepatitis. During treatment, all AIH persistently normalized clinical and biochemical parameters; after withdrawal, six patients maintained a sustained remission (follow‐up range: 12–63 months), while one relapsed.</jats:p><jats:p><jats:bold>Conclusions </jats:bold> In CD children with AIH, only GFD plus immunosuppressants determines a high remission rate. When clinical remission is reached, a prolonged immunosuppressive regimen induces a high sustained remission rate after treatment withdrawal, indicating that this regimen may prevent early relapse.</jats:p><jats:p> <jats:italic>Aliment Pharmacol Ther</jats:italic> <jats:bold>31</jats:bold>, 253–260</jats:p> Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience Alimentary Pharmacology & Therapeutics |
| doi_str_mv |
10.1111/j.1365-2036.2009.04186.x |
| facet_avail |
Online Free |
| finc_class_facet |
Chemie und Pharmazie Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjAzNi4yMDA5LjA0MTg2Lng |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjAzNi4yMDA5LjA0MTg2Lng |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Wiley, 2010 |
| imprint_str_mv |
Wiley, 2010 |
| issn |
0269-2813 1365-2036 |
| issn_str_mv |
0269-2813 1365-2036 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
dibiase2010autoimmuneliverdiseasesinapaediatricpopulationwithcoeliacdiseasea10yearsinglecentreexperience |
| publishDateSort |
2010 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Alimentary Pharmacology & Therapeutics |
| source_id |
49 |
| title |
Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_unstemmed |
Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_full |
Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_fullStr |
Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_full_unstemmed |
Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_short |
Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_sort |
autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| topic |
Pharmacology (medical) Gastroenterology Hepatology |
| url |
http://dx.doi.org/10.1111/j.1365-2036.2009.04186.x |
| publishDate |
2010 |
| physical |
253-260 |
| description |
<jats:title>Summary</jats:title><jats:p><jats:bold>Backgroud </jats:bold> Coeliac disease (CD) can be associated with liver disease. Gluten‐free diet (GFD) normalizes cryptogenic forms, but most likely not autoimmune hepatitis (AIH). For this condition, immunosuppressants represent the treatment. However, when these are stopped, AIH generally relapses.</jats:p><jats:p><jats:bold>Aim </jats:bold> To determine in CD children liver test abnormality frequency, the effect of GFD alone, or plus prolonged immunosuppressants on AIH course.</jats:p><jats:p><jats:bold>Methods </jats:bold> Coeliac disease patients with abnormal transaminases were selected; if transaminases <5 × UNL (upper normal limits), GFD alone was administered; if >5 × UNL, liver examinations and biopsy were performed. In AIH, immunosuppressants were administered (5 years). Treatment was stopped only if patients remained in remission during the entire maintenance period and normalized liver histology.</jats:p><jats:p><jats:bold>Results </jats:bold> A total of 140 out of 350 CD children had hypertransaminaemia: 133 cryptogenic disease, 7 AIH. GFD normalized only cryptogenic hepatitis. During treatment, all AIH persistently normalized clinical and biochemical parameters; after withdrawal, six patients maintained a sustained remission (follow‐up range: 12–63 months), while one relapsed.</jats:p><jats:p><jats:bold>Conclusions </jats:bold> In CD children with AIH, only GFD plus immunosuppressants determines a high remission rate. When clinical remission is reached, a prolonged immunosuppressive regimen induces a high sustained remission rate after treatment withdrawal, indicating that this regimen may prevent early relapse.</jats:p><jats:p> <jats:italic>Aliment Pharmacol Ther</jats:italic> <jats:bold>31</jats:bold>, 253–260</jats:p> |
| container_issue |
2 |
| container_start_page |
253 |
| container_title |
Alimentary Pharmacology & Therapeutics |
| container_volume |
31 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792343628137365511 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T16:54:41.391Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Autoimmune+liver+diseases+in+a+paediatric+population+with+coeliac+disease+%E2%80%93+a+10%E2%80%90year+single%E2%80%90centre+experience&rft.date=2010-01-01&genre=article&issn=1365-2036&volume=31&issue=2&spage=253&epage=260&pages=253-260&jtitle=Alimentary+Pharmacology+%26+Therapeutics&atitle=Autoimmune+liver+diseases+in+a+paediatric+population+with+coeliac+disease+%E2%80%93+a+10%E2%80%90year+single%E2%80%90centre+experience&aulast=FESTI&aufirst=D.&rft_id=info%3Adoi%2F10.1111%2Fj.1365-2036.2009.04186.x&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792343628137365511 |
| author | DI BIASE, A. R., COLECCHIA, A., SCAIOLI, E., BERRI, R., VIOLA, L., VESTITO, A., BALLI, F., FESTI, D. |
| author_facet | DI BIASE, A. R., COLECCHIA, A., SCAIOLI, E., BERRI, R., VIOLA, L., VESTITO, A., BALLI, F., FESTI, D., DI BIASE, A. R., COLECCHIA, A., SCAIOLI, E., BERRI, R., VIOLA, L., VESTITO, A., BALLI, F., FESTI, D. |
| author_sort | di biase, a. r. |
| container_issue | 2 |
| container_start_page | 253 |
| container_title | Alimentary Pharmacology & Therapeutics |
| container_volume | 31 |
| description | <jats:title>Summary</jats:title><jats:p><jats:bold>Backgroud </jats:bold> Coeliac disease (CD) can be associated with liver disease. Gluten‐free diet (GFD) normalizes cryptogenic forms, but most likely not autoimmune hepatitis (AIH). For this condition, immunosuppressants represent the treatment. However, when these are stopped, AIH generally relapses.</jats:p><jats:p><jats:bold>Aim </jats:bold> To determine in CD children liver test abnormality frequency, the effect of GFD alone, or plus prolonged immunosuppressants on AIH course.</jats:p><jats:p><jats:bold>Methods </jats:bold> Coeliac disease patients with abnormal transaminases were selected; if transaminases <5 × UNL (upper normal limits), GFD alone was administered; if >5 × UNL, liver examinations and biopsy were performed. In AIH, immunosuppressants were administered (5 years). Treatment was stopped only if patients remained in remission during the entire maintenance period and normalized liver histology.</jats:p><jats:p><jats:bold>Results </jats:bold> A total of 140 out of 350 CD children had hypertransaminaemia: 133 cryptogenic disease, 7 AIH. GFD normalized only cryptogenic hepatitis. During treatment, all AIH persistently normalized clinical and biochemical parameters; after withdrawal, six patients maintained a sustained remission (follow‐up range: 12–63 months), while one relapsed.</jats:p><jats:p><jats:bold>Conclusions </jats:bold> In CD children with AIH, only GFD plus immunosuppressants determines a high remission rate. When clinical remission is reached, a prolonged immunosuppressive regimen induces a high sustained remission rate after treatment withdrawal, indicating that this regimen may prevent early relapse.</jats:p><jats:p> <jats:italic>Aliment Pharmacol Ther</jats:italic> <jats:bold>31</jats:bold>, 253–260</jats:p> |
| doi_str_mv | 10.1111/j.1365-2036.2009.04186.x |
| facet_avail | Online, Free |
| finc_class_facet | Chemie und Pharmazie, Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjAzNi4yMDA5LjA0MTg2Lng |
| imprint | Wiley, 2010 |
| imprint_str_mv | Wiley, 2010 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 0269-2813, 1365-2036 |
| issn_str_mv | 0269-2813, 1365-2036 |
| language | English |
| last_indexed | 2024-03-01T16:54:41.391Z |
| match_str | dibiase2010autoimmuneliverdiseasesinapaediatricpopulationwithcoeliacdiseasea10yearsinglecentreexperience |
| mega_collection | Wiley (CrossRef) |
| physical | 253-260 |
| publishDate | 2010 |
| publishDateSort | 2010 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Alimentary Pharmacology & Therapeutics |
| source_id | 49 |
| spelling | DI BIASE, A. R. COLECCHIA, A. SCAIOLI, E. BERRI, R. VIOLA, L. VESTITO, A. BALLI, F. FESTI, D. 0269-2813 1365-2036 Wiley Pharmacology (medical) Gastroenterology Hepatology http://dx.doi.org/10.1111/j.1365-2036.2009.04186.x <jats:title>Summary</jats:title><jats:p><jats:bold>Backgroud </jats:bold> Coeliac disease (CD) can be associated with liver disease. Gluten‐free diet (GFD) normalizes cryptogenic forms, but most likely not autoimmune hepatitis (AIH). For this condition, immunosuppressants represent the treatment. However, when these are stopped, AIH generally relapses.</jats:p><jats:p><jats:bold>Aim </jats:bold> To determine in CD children liver test abnormality frequency, the effect of GFD alone, or plus prolonged immunosuppressants on AIH course.</jats:p><jats:p><jats:bold>Methods </jats:bold> Coeliac disease patients with abnormal transaminases were selected; if transaminases <5 × UNL (upper normal limits), GFD alone was administered; if >5 × UNL, liver examinations and biopsy were performed. In AIH, immunosuppressants were administered (5 years). Treatment was stopped only if patients remained in remission during the entire maintenance period and normalized liver histology.</jats:p><jats:p><jats:bold>Results </jats:bold> A total of 140 out of 350 CD children had hypertransaminaemia: 133 cryptogenic disease, 7 AIH. GFD normalized only cryptogenic hepatitis. During treatment, all AIH persistently normalized clinical and biochemical parameters; after withdrawal, six patients maintained a sustained remission (follow‐up range: 12–63 months), while one relapsed.</jats:p><jats:p><jats:bold>Conclusions </jats:bold> In CD children with AIH, only GFD plus immunosuppressants determines a high remission rate. When clinical remission is reached, a prolonged immunosuppressive regimen induces a high sustained remission rate after treatment withdrawal, indicating that this regimen may prevent early relapse.</jats:p><jats:p> <jats:italic>Aliment Pharmacol Ther</jats:italic> <jats:bold>31</jats:bold>, 253–260</jats:p> Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience Alimentary Pharmacology & Therapeutics |
| spellingShingle | DI BIASE, A. R., COLECCHIA, A., SCAIOLI, E., BERRI, R., VIOLA, L., VESTITO, A., BALLI, F., FESTI, D., Alimentary Pharmacology & Therapeutics, Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience, Pharmacology (medical), Gastroenterology, Hepatology |
| title | Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_full | Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_fullStr | Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_full_unstemmed | Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_short | Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_sort | autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| title_unstemmed | Autoimmune liver diseases in a paediatric population with coeliac disease – a 10‐year single‐centre experience |
| topic | Pharmacology (medical), Gastroenterology, Hepatology |
| url | http://dx.doi.org/10.1111/j.1365-2036.2009.04186.x |